3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine

3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine Suppliers list
Company Name: Amadis Chemical Company Limited  
Tel: 571-89925085
Email: sales@amadischem.com
Company Name: NewCan Biotech Limited  
Tel: +86-571-86912261 19975279805
Email: sales@newcanbio.com
Company Name: BOC Sciences  
Tel: 16314854226
Email: inquiry@bocsci.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Shanghai meikai technology co., ltd  
Tel: 021-68689288 15300790979
Email: info@mkbio.com.cn

3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine manufacturers

3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine Basic information
Product Name:3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine
Synonyms:1-(3,5-O-Dibenzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)cytosine;4-Amino-1-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-2(1H)-pyrimidinone;1-(3,5-O-DIBENZOYL-2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)CYTOSINE;3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine;2(1H)-Pyrimidinone, 4-amino-1-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-;3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-b-D-arabinocytidine;3’,5’-Di-O-benzoyl-2’-deoxy-2’-fluoro-alpha-D-arabino-cytidine;’,5’-Di-O-benzoyl-2’-deoxy-2’-fluoro-alpha-D-arabino-cytidine
CAS:128495-99-8
MF:C23H20FN3O6
MW:453.42
EINECS:
Product Categories:
Mol File:128495-99-8.mol
3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine Structure
3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine Chemical Properties
Melting point 213-215.5 °C
Boiling point 617.252±65.00 °C(Press: 760.00 Torr)(predicted)
density 1.440±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka4.263±0.10(predicted)
Safety Information
MSDS Information
3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine Usage And Synthesis
Uses3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
References[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005
3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine Preparation Products And Raw materials
Tag:3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-beta-D-arabinocytidine(128495-99-8) Related Product Information
5-Chloro-2'-deoxyuridine Raltitrexed Capecitabine 6-Mercaptopurine Broxuridine 4-Thiouridine